Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL
Reduced-duration outpatient blinatumomab shows promise as a context-adapted strategy for heavily pretreated pediatric patients with ALL. Given the small retrospective cohort, these findings should be interpreted with caution.
Authors
- David Gómez Almaguer
- Óscar González Llano
- Perla R. Colunga Pedraza
- José Carlos Jaime‐Pérez (ORCID: https://orcid.org/0000-0001-6804-9095)
- Julia Esther Colunga Pedraza
- Yahaira Valentina Jiménez Antolinez
- Claudia Gabriela Martínez Martínez
- Ingrid Gabriela López Reyna
- Andrés Gómez-De León
Institutions
- Universidad Autónoma de Nuevo León (MX)
- Hospital Universitario Dr José Eleuterio Gonzalez (MX)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1200/go-25-00469
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00